Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Catalyst Pharmaceuticals (CPRX) EPS (Basic): 2009-2024

Historic EPS (Basic) for Catalyst Pharmaceuticals (CPRX) over the last 16 years, with Dec 2024 value amounting to $1.38.

  • Catalyst Pharmaceuticals' EPS (Basic) rose 16.22% to $0.43 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.79, marking a year-over-year increase of 43.20%. This contributed to the annual value of $1.38 for FY2024, which is 105.97% up from last year.
  • Per Catalyst Pharmaceuticals' latest filing, its EPS (Basic) stood at $1.38 for FY2024, which was up 105.97% from $0.67 recorded in FY2023.
  • Catalyst Pharmaceuticals' EPS (Basic)'s 5-year high stood at $1.38 during FY2024, with a 5-year trough of $0.38 in FY2021.
  • Over the past 3 years, Catalyst Pharmaceuticals' median EPS (Basic) value was $0.80 (recorded in 2022), while the average stood at $0.95.
  • Per our database at Business Quant, Catalyst Pharmaceuticals' EPS (Basic) spiked by 132.26% in 2020 and then crashed by 47.22% in 2021.
  • Catalyst Pharmaceuticals' EPS (Basic) (Yearly) stood at $0.72 in 2020, then tumbled by 47.22% to $0.38 in 2021, then surged by 110.53% to $0.80 in 2022, then decreased by 16.25% to $0.67 in 2023, then surged by 105.97% to $1.38 in 2024.